Be Part of a Clinical Trial - If you are interested in joining a clinical trial or would like more information regarding clinical trials and/or which trials are currently being performed in our department, please call the Research Team (310) 825-6577.
- Understanding Quality of Life in Radiation & Chemotherapy in Bladder Cancer Patients
- Radiation Therapy Combined With Experimental Drugs for Bladder Cancer Which Has Spread
- Accelerated Whole Breast Irradiation
Head and Neck Cancer
- Combination of Low-Dose Focused Radiotherapy, Immunotherapy, and Transoral Robotic Surgery in HPV+ Head and Neck Cancer
- Radiation Therapy with Chemotherapy, Inoperable Lung Cancer
- Radiation Therapy & Radiofrequency Ablation, Inoperable Lung Tumors
- Radiation With or Without Immunotherapy for Early-Stage (Stage I or II) Inoperable Lung Cancer
- Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy (EXCALIBUR)
- Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial
- Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
- Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)
Soft Tissue Sarcomas
- CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study
- Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
- Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
- Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy (PSMA SRT)
- Flare Measurements, Human Irradiation Therapy
- Induction Chemotherapy & Attenuated Chemoradiotherapy
- Intra-Oral Mucosal Cell Sampling, Head & Neck Radiotherapy
- Erythropoietin & Breast Cancer Stem Cells
What is a Clinical Trial?
A clinical trial is a study conducted with patients, usually to evaluate a new treatment or medication. Each study is designed to answer specific scientific questions and to find new and better ways to help take care patients. The search for excellent treatment begins with basic research and careful study in the laboratory. This lab research, points out the new methods most likely to succeed, and, as much as possible, shows how to use them safely and effectively. The results of that research are then used in patient studies, hopefully leading to outcomes that will be able to help many people. Clinical trials help us find out if the promising new treatment is safe and effective for patients.
During a trial, more and more information is gained about a new treatment or medication, its risks, and how well it may or may not work. Standard treatments, the ones currently being used, are often the base for building new treatments. Many new treatments are designed on the basis of what has worked in the past, and in efforts to improve them. You may be interested in, or offered information regarding a clinical trial while visiting the Radiation Oncology Department. Learn as much as you can about the trial before you make up your mind. Only patients who choose to do so, actually take part in a clinical trial. It is often helpful to talk to your physician, family members, relatives or friends about whether or not to join a trial.
Clinical Trials Director
Director of Clinical Trials
UCLA Dept. of Radiation Oncology
200 Med Plaza, Suite B265
Los Angeles, CA 90095-6951
Ph: (310) 267-8954
Fx: (310) 794-1984